Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.581NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.330NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.205NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.177NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.301NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.308NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.210NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.325NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.590NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.116NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.496NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.438.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.49 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HH.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.43.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.332NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JB.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.86.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JW.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.6.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.141NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.591NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.468NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.131 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.586NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.366NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.380NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.148NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.382NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.356NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.376NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.607NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.163NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.337NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.158NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.602NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.289NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.7.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDHNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.48NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EK.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.66NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used